1 year return (CAGR)
35.66%
Autolus Therapeutics Ltd Exchange (NASDAQ, USD)
AUTL
1.94
+0.06 (+3.19%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-14.65%
5 year return (CAGR)
-23.22%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
516.36M
Price/Sales
4.40
Ent value
763.33M
Price/Book
6.90
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.86 |
| Daily high | 1.95 |
| Daily low | 1.85 |
| Daily Volume | 1.48M |
| All-time high | 48.01 |
| 1y analyst estimate | 8.72 |
| Beta | 2.00 |
| EPS (TTM) | -1.05 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 10 Mar 2026 |
Downside potential
Loading...
Downside potential data
| AUTL | S&P500 | |
| Current price drop from All-time high | -95.96% | -2.19% |
| Highest price drop | -97.63% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -81.72% | -10.68% |
| Avg time to new high | 188 days | 12 days |
| Max time to new high | 1969 days | 1805 days |
News
